Loading organizations...
Loading organizations...
Key people at Shanghai Healthcare Capital.
Key people at Shanghai Healthcare Capital.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 26, 2026 | Fortitude Biomedicines | $13.0M Seed | Yunhai Wang, Samuel Guo | Everjoy Fortune, Taihill Venture |
| Dec 30, 2025 | Haimai Medical | $14.3M Series A | — | IDG Capital |
| Nov 1, 2023 | Sanegene Bio | $80.0M Series A | — | Qiming Venture Partners, K2 Venture Partners, Northern Light Venture Capital, Shenzhen Capital Group, TF Capital |
| May 19, 2023 | Taichu Biotechnology | $56.9M Series A | IDG Capital | Yijing Capital |
| Mar 27, 2023 | ArriVent Biopharma | $155.0M Series B | Elena Viboch, James Healy | AIHC Capital, Catalio Capital Management, HBM Healthcare Investments, Hongshan Capital Group (Sequoia Capital China), Infinitum Asset Management, Lilly Asia Ventures, Octagon Capital, Carl Gordon, Sirona Capital, Terra Magnum Capital Partners, Unicorn Capital, Zoo Capital |
| Aug 18, 2021 | Ranok Therapeutics | $40.0M Series B | Zhihua Yu, Hong Wen | Wu Capital, Zhongguancun Kaiyuan Capital |
| Sep 24, 2020 | Immvira | $10.0M Series B | Shanghai Healthcare Capital | — |